NNelo Trade
← Back to Market News
September 22, 2026 at 08:06 PM UTC

AYTU BIOPHARMA, INC reports financial results in SEC 8-K

AYTU BIOPHARMA, INC filed an 8-K covering results of operations or financial condition. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: September 22, 2026 at 08:05 PM UTC

Open official source